C57BL/6JCya-Cd72em1/Cya
Common Name
Cd72-KO
Product ID
S-KO-01430
Backgroud
C57BL/6JCya
Strain ID
KOCMP-12517-Cd72-B6J-VA
When using this mouse strain in a publication, please cite “Cd72-KO Mouse (Catalog S-KO-01430) were purchased from Cyagen.”
Product Type
Age
Genotype
Sex
Quantity
Basic Information
Strain Name
Cd72-KO
Strain ID
KOCMP-12517-Cd72-B6J-VA
Gene Name
Product ID
S-KO-01430
Gene Alias
CD72c, Ly-19, Ly-32, Lyb-2, Ly-m19
Background
C57BL/6JCya
NCBI ID
Modification
Conventional knockout
Chromosome
Chr 4
Phenotype
Datasheet
Application
--
Strain Description
Ensembl Number
ENSMUST00000107926
NCBI RefSeq
NM_007654
Target Region
Exon 1~4
Size of Effective Region
~2.1 kb
Overview of Gene Research
CD72, a regulatory co-receptor, is a member of the C-type lectin superfamily. It is expressed on B cells from pro-B to mature B-cell stages and plays a role in regulating lymphocyte responsiveness. Its cytoplasmic tail contains immunoreceptor tyrosine-based inhibitory motifs (ITIMs), suggesting a negative regulatory function, and it is involved in pathways related to immune responses and autoimmunity [1,2,4].
In mouse models, CD72-deficient mice demonstrate that CD72 is a non-redundant regulator of B-cell development and a negative regulator of B-cell responsiveness [2]. In the context of systemic lupus erythematosus (SLE), CD72 polymorphisms associate with SLE in both human and mice, and CD72-/-mice develop relatively severe lupus-like disease. CD72 specifically recognizes self-antigens like Sm/RNP and ribosomes, inhibiting B-cell responses to these self-antigens and thus suppressing the development of SLE [1,3]. In a murine scleroderma model, CD72-deficient mice showed less skin and lung fibrosis compared to wild-type mice, indicating its role in fibrosis development [5].
In summary, CD72 is a crucial regulator in B-cell function, playing a key role in maintaining self-tolerance and preventing autoimmunity. Gene knockout mouse models, such as CD72-/-mice, have been instrumental in revealing its functions in diseases like SLE and scleroderma, providing insights into potential therapeutic targets for these autoimmune diseases.
References:
1. Tsubata, Takeshi. 2019. CD72 is a Negative Regulator of B Cell Responses to Nuclear Lupus Self-antigens and Development of Systemic Lupus Erythematosus. In Immune network, 19, e1. doi:10.4110/in.2019.19.e1. https://pubmed.ncbi.nlm.nih.gov/30838156/
2. Parnes, J R, Pan, C. . CD72, a negative regulator of B-cell responsiveness. In Immunological reviews, 176, 75-85. doi:. https://pubmed.ncbi.nlm.nih.gov/11043769/
3. Akatsu, Chizuru, Tsuneshige, Takahiro, Numoto, Nobutaka, Ito, Nobutoshi, Tsubata, Takeshi. 2024. CD72 is an inhibitory pattern recognition receptor that recognizes ribosomes and suppresses production of anti-ribosome autoantibody. In Journal of autoimmunity, 146, 103245. doi:10.1016/j.jaut.2024.103245. https://pubmed.ncbi.nlm.nih.gov/38754236/
4. Wu, Hsin-Jung, Bondada, Subbarao. . Positive and negative roles of CD72 in B cell function. In Immunologic research, 25, 155-66. doi:. https://pubmed.ncbi.nlm.nih.gov/11999169/
5. Zhao, Chunyan, Matsushita, Takashi, Ha Nguyen, Vinh Thi, Takehara, Kazuhiko, Hamaguchi, Yasuhito. 2019. CD22 and CD72 contribute to the development of scleroderma in a murine model. In Journal of dermatological science, 97, 66-76. doi:10.1016/j.jdermsci.2019.12.007. https://pubmed.ncbi.nlm.nih.gov/31883832/
Quality Control Standard
Sperm Test
Pre-cryopreservation: Measurement of sperm concentration, determination of sperm viability.
Post-cryopreservation: A vial of cryopreserved sperms is selected for in-vitro fertilization from each batch.
Environmental Standards:SPF
Available Region:Global
Source:Cyagen
Contact Us
Connect with our experts for your custom animal model needs. Please fill out the form below to start a conversation or request a quote.
Cyagen values your privacy. We’d like to keep you informed about our latest offerings and insights. Your preferences:
You may unsubscribe from these communications at any time. See our Privacy Policy for details on opting out and data protection.
By clicking the button below, you consent to allow Cyagen to store and process the personal information submitted in this form to provide you the content requested.
